Principal Financial Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-901
| Closed | -$15.7K | – | 2480 |
|
|
2024
Q1 | $15.7K | Sell |
901
-96
| -10% | -$1.67K | ﹤0.01% | 2415 |
|
|
2023
Q4 | $15.6K | Sell |
997
-110
| -10% | -$1.72K | ﹤0.01% | 2393 |
|
|
2023
Q3 | $54.8K | Buy |
1,107
+115
| +12% | +$5.69K | ﹤0.01% | 2340 |
|
|
2023
Q2 | $77.6K | Buy |
992
+231
| +30% | +$18.1K | ﹤0.01% | 2323 |
|
|
2023
Q1 | $68.9K | Buy |
761
+10
| +1% | +$906 | ﹤0.01% | 2346 |
|
|
2022
Q4 | $88.6K | Buy |
+751
| New | +$88.6K | ﹤0.01% | 2313 |
|